OPCH vs TOI
OPCH: Option Care Health is the nation’s largest independent provider of home and alternate site infusion services, delivering cost-effective, patient-centered care for complex chronic and acute conditions. TOI: The Oncology Institute is a value-based oncology care provider that manages outpatient cancer treatment through a national network of clinics and integrated specialty pharmacies.
Side-by-side fundamentals
| Metric | OPCH | TOI | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $21.15 | $5.29 | |
| Market cap as of 2026-07-23 | $3.3B | $529M | |
| P/E as of 2026-07-23 | 16.17 | n/a | |
| PEG as of 2026-07-23 | 1.50 | n/a | |
| Net margin as of 2026-07-23 | +3.6% | -8.0% | OPCH higher |
| Gross margin as of 2026-07-23 | +19.2% | +15.1% | OPCH higher |
| Operating margin as of 2026-07-23 | +5.8% | -6.0% | OPCH higher |
| ROE as of 2026-07-23 | +15.3% | -482.6% | OPCH higher |
| ROA as of 2026-07-23 | +6.0% | -26.5% | OPCH higher |
| Debt / equity as of 2026-07-23 | 0.86 | 14.58 | OPCH lower |
| Revenue growth (YoY) as of 2026-07-23 | +9.3% | +35.4% | TOI higher |
| Revenue CAGR (3y) SEC XBRL | +13.4% | +25.8% | TOI higher |
| Beta as of 2026-07-23 | 0.61 | 0.36 | |
| 1-year return as of 2026-07-22 close | -29.0% | +59.2% | TOI higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.